🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great work from Chris Labaki BIDMC , led with Eddy Saad and #KatrineMadsen. Large team effort led together with Lisa Henske Brigham and Women's Hospital Sachet Ashok Shukla MD Anderson Cancer Center and Eli Van Allen and Toni Choueiri, MD Dana-Farber KidneyCAN Kidney Cancer COA - Chromophobe and Oncocytic Tumor Alliance OncLive.com

Lucky to be part of such an exceptional group with the leadership/mentorship of David Braun Working towards better outcomes for patients with kidney cancer

Novel Insights into Chromophobe Renal Cell Carcinoma Biology and Potential Therapeutic Strategies David Braun Yale Cancer Center #KidneyCancer onclive.com/view/novel-ins…

Chromophobe renal cell carcinoma is difficult to treat - Research in Journal of Clinical Oncology provides better understanding of this rare kidney cancer, potential treatment pathways & immunotherapy strategies. Dana-Farber Lank Center for Genitourinary Oncology Eddy Saad Chris Labaki BIDMC ➡️ bit.ly/3IhLT8d

And we're off! #KCRS25 begins with an important session on variant histologies of RCC, with Bradley McGregor giving an overview of papillary RCC Kidney Cancer

Bryan Lewis KidneyCAN with a moving and touching speech at the opening ceremony of #KCRS25

Great talk by Wenxin (Vincent) Xu regarding the major role of KIM-1 in guiding therapeutic decision-making in #RCC KidneyCAN #KCRS25

Powerful words Chuck Stravin about the importance of research funding and continuous efforts, with the goal of improving patient outcomes KidneyCAN #KCRS25

Breaking out of the group chat💥 Four years ago I was recovering from surgery and messaging my support system, the “chromophobe six”, about the lack of research, info, and community for #chRCC. There wasn’t a singled funded foundation grant for chRCC at the time. This evening I